ULTRAHUMAN LAUNCHES M2 LIVE IN THE US

Ultrahuman is bringing its metabolic health platform M2 Live to the United States, and the headline number is that it starts at $99 per month with no prescription needed. The subscription integrates glucose data from Abbott's over-the-counter Lingo continuous glucose monitor with the company's own Ring and its Blood Vision service, which analyses more than 100 blood biomarkers. It is available through the Ultrahuman website "in the coming weeks".

The move is a significant step for the company, which helped popularise glucose monitoring for the wellness crowd when it launched its first metabolic tracking platform in 2021. M2 Live is designed for adults who want to understand how food, exercise, stress, and sleep affect their bodies in real time. It is also available to people with prediabetes who are looking to improve their metabolic health. The company says the goal is to "become one of the most affordable wearable metabolic health platforms in the U.S." in the U.S.

you may like

GOOGLE ANNOUNCES HEALTH CLI FOR DEVS WHO WANT TO SCRIPT FITNESS DATA

AMAZON ECHO HUB GETS MASSIVE UPDATE

THE HARD DATA PROBLEM AT THE HEART OF LONGEVITY AI

THE HARDWARE & THE SUBSCRIPTION

Each Lingo sensor costs $129 and can be worn for up to 14 days, giving users continuous glucose data. The $99 monthly subscription covers the platform access itself, not the sensors, which means the ongoing cost depends on how consistently you wear them. At full-time use, a user would need roughly two sensors per month, bringing the total to about $228 per month before any bulk discounts or introductory offers.

That is still cheaper than most prescription CGM solutions for people without diabetes, and well below the price of some competing wellness platforms that charge $300 or more per month. The tradeoff is depth versus focus. M2 Live is not just a glucose graph. It layers in sleep quality, activity levels, recovery, stress, heart rate variability, and body temperature from the Ultrahuman Ring, plus the Blood Vision panel of 100 biomarkers for users who opt into blood testing.

AI LAYER

Powering the whole thing is Jade AI, Ultrahuman's real-time biointelligence engine. It analyses health data and connects glucose patterns to lifestyle factors such as logged sleep, heart rate variability, meals, and workouts. Instead of just showing a spike, the system tries to explain why it happened. That is a meaningful step beyond raw data presentation. The same sensor data that says is more useful when it says

M2 Live includes a daily Metabolic Score ranging from 0 to 100, personalised Food Scores, real-time spike alerts, workout-focused Fueling Scores, and access to OGDb, which appears to be a database of food glycemic responses.

THE SCIENCY STUFF

The Metabolic Score has been clinically validated through a multi-centre study published in Nature, demonstrating its ability to distinguish between non-diabetic and prediabetic individuals. Ultrahuman points to recent collaborations with Stanford University, Bangor University, La Trobe University, and the Mayo Clinic as part of its broader metabolic health research efforts.

The company cites a statistic that only one in eight US adults is metabolically healthy, contributing to conditions such as Type 2 diabetes and cardiovascular disease. The pitch is that real-time metabolic insights can help users make better health decisions before serious problems develop. That is a legitimate medical claim, but also a classic direct-to-consumer positioning. The validation from Nature matters, and the academic partnerships give the platform some institutional credibility that many wellness wearables lack.

THE TIMING

Consumer health technology is moving rapidly beyond simple fitness tracking and into deeper health monitoring. The launch comes at a moment when companies like Levels, Nutrisense, and Signos have been fighting for a share of the wellness CGM market at roughly similar price points. What Ultrahuman brings that others do not is the integrated ring and blood biomarker ecosystem. A Levels subscription without a ring is just a glucose graph with coaching. M2 Live brings ring data, blood data, and AI analysis into a single subscription.

The catch is that the ring is sold separately, and Blood Vision is an additional service. The total cost of going all-in on Ultrahuman's stack is significantly higher than $99 per month. But for users who already own the ring, M2 Live becomes a relatively inexpensive add-on that turns a fitness tracker into a metabolic health station.

BUT DO THE USERS WANT IT

The no-prescription piece is the sleeper here. Most CGM solutions require a doctor's note or a telehealth consultation, even for wellness use. Abbott's Lingo is over-the-counter, and Ultrahuman is leaning into that by making M2 Live available without a prescription. That removes a friction point that has limited the wellness CGM market to motivated early adopters.

The question is whether enough consumers want this level of metabolic feedback. The company is betting that people who already wear an Oura or Whoop will be willing to add a CGM and pay $100 plus sensors each month to see the full picture. That is a specific demographic, but the market for that demographic is growing, and Ultrahuman has positioned itself to capture it.

what to read next

BITZERO BUILT DATA CENTRES NOBODY COULD BLOCK AND IT JUST HIT NASDAQ

FOX ACQUIRES ROKU FOR $22BN, CREATING 3RD LARGEST US TV PLAYER

SF CITY ATTORNEY DEMANDS APPLE AND GOOGLE REMOVE 13+ NUDIFY APPS

For now, M2 Live is available through the Ultrahuman website "in the coming weeks". No prescription, no doctor visit. Just a subscription, a sensor, and a ring you already own.